Combination Intervention to Enhance Treatment Engagement and Viral Suppression Among Sexual and Gender Minority Youth in Nigeria
Recruiting
N/A
Interventional Study
HIV
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 15 – 29
- Sex
- Male
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 110 (estimated)
- Sponsor
- Northwestern University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study will adapt and test a combination peer navigation and mHealth approach, Intensive Combination Approach to Rollback the Epidemic in Nigeria (iCARE Nigeria), to improve HIV treatment engagement, medication adherence and viral suppression among YMSM and YTW, ages 15-29.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* HIV seropositive
* registered as a patient at one of the collaborating key population (KP)-focused community centers
* male sex at birth
* identify as YMSM or YTW (or report a history of sex with men)
* understand and read basic English, Yoruba, or Pidgin English
* intention t…
Contacts